Klaria Pharma Holding AB

Klaria Pharma Holding AB

2.35
SEK
+0.45
(+23.68%)
-0.61EPS
Nov 26Next Earn

Important Dates

Klaria Pharma Holding AB TEMP's next confirmed earnings release is scheduled for November 26, 2026.

Earnings Date11/26/2026

Share Statistics

As of June 30, 2026, Klaria Pharma Holding AB TEMP has 64.99M shares outstanding.

Shares Outstanding64.99M

Financial Position

As of June 30, 2026, Klaria Pharma Holding AB TEMP maintains a current ratio of 0.20, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.

Current Ratio0.20
Quick Ratio0.14

Financial Efficiency

SEK

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -88.24, reflecting losses generated across the asset base. The company generates approximately 38,250.00 in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-88.24
Revenue Per Employee38,250.00
Employee Count4.00

Income Statement

SEK

Over the twelve months ended June 30, 2026, Klaria Pharma Holding AB TEMP generated 153,000.00 in revenue and converted that into -38.72M in net income, yielding earnings per share of -0.61. EBITDA reached -23.18M, while operating income came in at -31.61M.

Revenue153,000.00
Operating Income-31.61M
Pretax Income-38.72M
Net Income-38.72M
EBITDA-23.18M
EBIT-31.61M
Earnings Per Share (EPS)-0.61

Balance Sheet

SEK

These figures are as of June 30, 2026. Total book value stands at -33.61M, with working capital of -48.82M providing operational flexibility.

Cash & Cash Equivalents8.47M
Net Debt-8.47M
Equity (Book Value)-33.61M
Book Value Per Share-0.52
Working Capital-48.82M

Cash Flow

SEK

Klaria Pharma Holding AB TEMP produced -48.51M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -48.51M - equivalent to -0.77 per share.

Operating Cash Flow-48.51M
Free Cash Flow-48.51M
FCF Per Share-0.77

Margins

These figures cover the twelve months ended June 30, 2026. The operating margin of -20,660.13 and net profit margin of -25,306.54 provide insight into operational efficiency.

Operating Margin-20,660.13
Pretax Margin-25,306.54
Profit Margin-25,306.54
EBITDA Margin-15,148.37